Gilead Sciences Inc. (GILD)
Price to Operating Profit (P/OP)
since 2005
Difficulty: Beginner
Calculation
Gilead Sciences Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income (loss) from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | 10.15 | = | 65.28 | ÷ | 6.43 | 6.43 | = | 8,200,000 | ÷ | 1,275,510,558 |
| Dec 31, 2017 | 7.45 | = | 80.36 | ÷ | 10.78 | 10.78 | = | 14,124,000 | ÷ | 1,309,967,781 |
| Dec 31, 2016 | 5.23 | = | 70.50 | ÷ | 13.49 | 13.49 | = | 17,633,000 | ÷ | 1,307,066,900 |
| Dec 31, 2015 | 5.50 | = | 89.36 | ÷ | 16.24 | 16.24 | = | 22,193,000 | ÷ | 1,366,845,691 |
| Dec 31, 2014 | 10.19 | = | 104.43 | ÷ | 10.25 | 10.25 | = | 15,265,000 | ÷ | 1,489,401,683 |
| Dec 31, 2013 | 28.54 | = | 83.95 | ÷ | 2.94 | 2.94 | = | 4,523,999 | ÷ | 1,538,252,914 |
| Dec 31, 2012 | 16.28 | = | 42.89 | ÷ | 2.63 | 2.63 | = | 4,010,175 | ÷ | 1,522,392,518 |
| Dec 31, 2011 | 9.02 | = | 22.58 | ÷ | 2.50 | 2.50 | = | 3,789,841 | ÷ | 1,514,630,722 |
| Dec 31, 2010 | 7.82 | = | 19.49 | ÷ | 2.49 | 2.49 | = | 3,962,222 | ÷ | 1,590,529,288 |
| Dec 31, 2009 | 12.16 | = | 23.76 | ÷ | 1.95 | 1.95 | = | 3,529,221 | ÷ | 1,806,757,972 |
| Dec 31, 2008 | 15.24 | = | 22.40 | ÷ | 1.47 | 1.47 | = | 2,678,541 | ÷ | 1,821,909,204 |
| Dec 31, 2007 | 18.80 | = | 21.90 | ÷ | 1.17 | 1.17 | = | 2,164,507 | ÷ | 1,857,740,064 |
| Dec 31, 2006 | — | = | 17.65 | ÷ | -0.41 | -0.41 | = | -758,753 | ÷ | 1,858,655,664 |
| Dec 31, 2005 | 25.01 | = | 15.03 | ÷ | 0.60 | 0.60 | = | 1,111,102 | ÷ | 1,849,138,544 |
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).
1 USD $
2 Data adjusted for splits and stock dividends.
3 Close price on the filing date of Gilead Sciences Inc.’s Annual Report.
Comparison to Competitors
Gilead Sciences Inc., P/OP, long-term trends, comparison to competitors
| Gilead Sciences Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Celgene Corp. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | 10.15 | 36.64 | 18.35 | — | 11.46 | 11.13 | 12.13 | 17.53 |
| Dec 31, 2017 | 7.45 | 60.88 | 19.63 | — | 12.71 | 13.70 | 15.21 | 16.71 |
| Dec 31, 2016 | 5.23 | 24.25 | 10.49 | — | 12.64 | 11.08 | 28.40 | 28.70 |
| Dec 31, 2015 | 5.50 | 19.80 | 11.61 | — | 13.07 | 12.09 | 34.53 | 30.74 |
| Dec 31, 2014 | 10.19 | 27.50 | 28.64 | — | 19.13 | 23.10 | 39.23 | 49.17 |
| Dec 31, 2013 | 28.54 | 22.79 | 14.31 | — | 16.19 | 28.29 | 36.98 | 42.99 |
| Dec 31, 2012 | 16.28 | 6.82 | 10.44 | 33.93 | 12.22 | 20.04 | 23.68 | 35.11 |
| Dec 31, 2011 | 9.02 | 15.35 | — | 14.30 | 12.48 | 16.87 | 22.70 | — |
| Dec 31, 2010 | 7.82 | 11.92 | — | 22.62 | 8.79 | 12.72 | 24.91 | — |
| Dec 31, 2009 | 12.16 | 13.54 | — | 12.91 | 10.12 | 11.26 | 32.72 | — |
| Dec 31, 2008 | 15.24 | 14.66 | — | 8.50 | 9.70 | 12.85 | — | — |
| Dec 31, 2007 | 18.80 | 18.76 | — | 11.43 | 12.44 | 24.01 | 52.12 | — |
| Dec 31, 2006 | — | 40.49 | — | — | 19.54 | 36.59 | 114.94 | — |
| Dec 31, 2005 | 25.01 | 15.48 | — | 15.01 | 17.96 | 66.33 | 169.22 | — |
Based on: 10-K (filing date: 2019-02-26), 10-K (filing date: 2018-02-27), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-25), 10-K (filing date: 2014-02-25), 10-K (filing date: 2013-02-27), 10-K (filing date: 2012-02-23), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-03-01), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-02-27), 10-K (filing date: 2006-03-03).